Mohs micrographic surgery in a patient with a deep brain stimulator: A review of the literature on implantable electrical devices

Dermatologic Surgery

Volumn 30, Issue 7, 2004, Pages 1021-1030

  Martinelli, Paul T ^a   Schulze, Keith E ^b   Nelson, Bruce R ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Dermatologic Surgery Center of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; ENTACAPONE; PRAMIPEXOLE;

AGED; BRAIN DEPTH STIMULATION; CASE REPORT; CAUTERIZATION; CHEMOSURGERY; DEFIBRILLATOR; DEVICE; ELECTRICAL EQUIPMENT; ELECTROMAGNETIC FIELD; ELECTROSURGERY; HEMOSTASIS; HUMAN; IMPLANT; INTRAOPERATIVE PERIOD; MALE; PARKINSON DISEASE; POPULATION DYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SKIN SURGERY;

AGED; CARCINOMA, SQUAMOUS CELL; DEFIBRILLATORS, IMPLANTABLE; EAR NEOPLASMS; ELECTROMAGNETIC FIELDS; EQUIPMENT DESIGN; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MOHS SURGERY; PACEMAKER, ARTIFICIAL; PARKINSON DISEASE; PRACTICE GUIDELINES;

EID: 3042743274     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30308.x     Document Type: Review

References (103)

1. Kinsella K, Velkoff VA. An aging world: 2001 [Internet]. Washington (DC): U.S. Census Bureau, 2001 Nov. Available from: http://www.census.gov/prod/ 2001pubs/p95-01-1.pdf.
2. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
3. Herndon CM, Young K, Herndon AD, Dole EJ. Parkinson's disease revisited. J Neurosci Nurs 2000;32:216-21.
4. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older persons. N Engl Med 1996;334:71-6.
5. Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am J Cardiol 1992;69:331-8.
6. Fauci AS, Braunwald E, Isselbacher KJ, eds. Harrison's Principles of Internal Medicine, 14th edn. New York: McGraw-Hill Co, 1998:2356.
7. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-9.
8. Jankovic J, Tolosa E. Parkinson's Disease and Movement Disorders. Maryland: Williams & Wilkins, 1993.
9. Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC. Is essential tremor benign. Neurology 1991;41:1982-3.
10. Questions and Answers About Activa Parkinson's Disease Therapy [Internet]. Minneapolis: Medtronic, c2004. Available from: http://www.medtronic. com/neuro/parkinsons/activa_qa.html.
11. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-6.
12. Siegfried J. Therapeutic stereotactic procedures on the thalamus for motor movement disorders. Acta Neurochir (Wien) 1993;124:14-8.
13. Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol 1983;46:68-83.
14. Blond S, Caparros-Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62-8.
15. Hubble JP, Busenbark KL, Wilkinson S, et al. Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Mov Disord 1997;12:337-41.
16. Obswegger AA, Uitti RJ, White RJ, et al. Quantitative and qualitative outcome measures after thalamic deep brain stimulation to treat disabling tremors. Neurosurgery 2001;48:274-84.
17. Benabid AL, Pollak P, Gao D, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-14.
18. Hubble JP, Busenbark KL, Wilkinson S, et al. Deep brain stimulation for essential tremor. Neurology 1996;46:1150-3.
19. Schuurman PR, Bosch DA, Bossuyt PMM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461-8.
20. Geny C, Nguyen JP, Pollin B, et al. Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord 1996;11:489-94.
21. Lyons KE, Koller WC, Wilkinson SB, Pahwa R. Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor. J Neurol Neurosurg Psychiatry 2001;71:682-4.
22. Krauss JK, Simpson RK, Ondo WG, et al. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery 2001;48:535-43.
23. Kumar K, Kelly M, Toth C. Deep brain stimulation of the ventral intermediate nucleus of the thalamus for control of tremors in Parkinson's disease and essential tremor. Stereotact Funct Neurosurg 1999;72:47-61.
24. Caparros-Lefebvre D, Ruchoux MM, Blond S, Petit H, Percheron G. Long-term thalamic stimulation in Parkinson's disease: postmortem anatomoclinical study. Neurology 1994;44:1856-60.
25. Bergman H, Wickmann T, DeLong MR. Reversal of experimental parkinsonism by lesion of the subthalamic nucleus. Science 1990;249:1436-8.
26. Gao DM, Benazzouz A, Piallat B, et al. High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey. Neuroscience 1999;88:201-12.
27. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-5.
28. Kitagawa M, Murata J, Kikuchi S, et al. Deep brain stimulation of subthalamic area for severe proximal tremor. Neurology 2000;55:114-6.
29. Fraix V, Pollak P, Van Blercom N, et al. Effect of subthalamic stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology 2000;55:1921-3.
30. Limousin-Dowsey P, Pollak P, Van Blercom N, et al. Thalamic, subthalamic nucleus, and internal pallidum stimulation in Parkinson's disease. J Neurol 1999;246(Suppl 2):II42-5.
31. Krack P, Poepping M, Weinert D, Schrader B, Deuschl G. Thalamic, pallidal, or subthalamic surgery for Parkinson's disease? J Neurol 2000;247(Suppl 2):11122-34.
32. Benabid AL, Krack PP, Benazzouz A, et al. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology 2000;55:S40-4.
33. Moro E, Scerrati M, Romito LM, et al. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-90.
34. Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001;70:464-70.
35. Levy R, Hutchison WD, Lozano AM, Dostrovsky JO. High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 2000;20:7766-75.
36. Katayama Y, Kasai M, Ohima H, et al. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-in-tolerant patients. J Neurosurg 2001;95:213-21.
37. Henderson JM, Pell M, O'Sullivan DJ, et al. Postmortem analysis of bilateral subrhalamic electrode implants in Parkinson's disease. Mov Disord 2002;17:133-7.
38. Figueiras-Mendez R, Regidor I, Riva-Meana C, Magarinos-Ascone CM. Further supporting evidence of beneficial subthalamic stimulation in Parkinson's patients. Neurology 2002;58:469-70.
39. Wilson JH, Lattner S, Jacob R, Stewart R. Electrocautery does not interfere with the function of the automatic implantable cardioverter defibrillator. Ann Thorac Surg 1991;51:225-6.
40. Blaustein AS. Preoperative and perioperative management of cardiac patients undergoing noncardiac surgery. Cardiol Clin 1995;13:149-61.
41. Bourke ME. The patient with a pacemaker or related device. Can J Anaesth 1996;43:R24-41.
42. Mangar D, Atlas GM, Kane PB. Electrosurgery-induced pacemaker malfunction during surgery. Can J Anaesth 1991;38:616-8.
43. Madigan JD, Choudhri AF, Chen J, et al. Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg 1999;230:639-47.
44. Riordan AT, Gamache C, Fosko SW. Electrosurgery and cardiac devices. J Am Acad Dermatol 1997;37:250-5.
45. Fetzer-Fowler SJ. Caring for the ambulatory surgical patient who has a pacemaker. II. ntraoperative hazards and postoperative care. J Post Anesth Nurs 1993;8:174-82.
46. Sebben JE. Electrosurgery and cardiac pacemakers. J Am Acad Dermatol 1983;9:457-63.
47. LeVasseur JG, Kennard CD, Finley EM, Muse RK. Dermatologic electrosurgery in patients with implantable cardioverter-defibrillators and pacemakers. Dermatol Surg 1998;24:233-40.
48. El-Gamal HM, Dufresne RG, Saddler K. Electrosurgery, pacemakers, and ICDs: a survey of precautions and complications experienced by cutaneous surgeons. Dermatol Surg 2001;27:385-90.
49. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart 2001;86:246-8.
50. Chauvin M, Crenner F, Brechenmacher C. Interaction between permanent cardiac pacing and electrocautery: the significance of electrode position. PACE 1992;15:2028-33.
51. Weaver J, Kim SJ, Torres A. Cutaneous electrosurgery in a patient with a deep brain stimulator. Dermatol Surg 1999;25:415-7.
52. Moses HW, Miller BD, Moulton KP, Schneider JA. A Practical Guide to Cardiac Pacing. Philadelphia: Lippincott, Williams & Wilkins, 2000.
53. Zaidan JR. Pacemakers. Anesthesiology 1984;60:319-34.
54. Das G, Eaton J. Pacemaker malfunction following transthoracic countershock. PACE 1981;4:487-90.
55. O'Neill MJ, Davis D. Pacemakers in noncardiac surgery. Surg Clin North Am 1983;63:1103-12.
56. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
57. Naccarelli GV, Veltri EP. Implantable Cardioverter-Defibrillators. Cambridge: Blackwell Scientific Publications, 1993.
58. Boughton RS, Spencer SK. Electrosurgical fundamentals. J Am Acad Dermatol 1987;16:862-7.
59. Bennet RG. Fundamentals of Cutaneous Surgery. St. Louis: Mosby 1998, 574-7.
60. Erdman S, Levinsky L, Strasberg B, Agmon J, Levy MJ. Use of the Shaw scalpel in pacemaker operations. J Thorac Cardiovasc Surg 1985;89:304-7.
61. Amar D, Fogel DH, Shah JP. The Shaw hemostatic scalpel as an alternative to electrocautery in patients with pacemakers. Anesthesiology 1996;85:223.
62. Farnworth TK, Beals SP, Manwaring KH, Trepeta RW. Comparison of skin necrosis in rats by using a new microneedle electocautery, standard-size needle electrocautery, and the Shaw hemostatic scalpel. Ann Plast Surg 1993;31:164-7.
63. Sebben JE. The status of electrosurgery in dermatologic practice. J Am Acad Dermatol 1988;19:542-9.
64. Greene LF, Merideth J. Transurethral operations employing high frequency electrical currents in patients with demand cardiac pacemakers. J Urol 1972;108:446-8.
65. Batra YK, Bali YM. Effect of coagulating and cutting current on a demand pacemaker during transurethral resection of the prostate: a case report. Can Anaesth Soc J 1978;25:65-6.
66. Smith RB. Pacemaker malfunction from urethral electrocautery. JAMA 1971;218:256.
67. O'Donoghue JK. Inhibition of demand pacemaker by electrosurgery. Chest 1973;64:665-6.
68. Lerner SM. Suppression of a demand pacemaker by transurethral electrocautery. Anesth Analg 1973;52:703-6.
69. Dresner DL, Lebowitz PW. Atrioventricular sequential pacemaker inhibition by transurethral electrosurgery. Anesthesiology 1998;68:599-601.
70. Wajszuck WJ, Mowry FM, Dugan NL. Deactivation of a demand pacemaker by transurethral electrocautery. N Engl J Med 1969;280:34-5.
71. Domino KB, Smith TC. Electrocautery-induced reprogramming of a pacemaker using a precordial magnet. Anesth Analg 1983;62:609-12.
72. Shapiro WA, Roizen MF, Singleton MA, et al. Intraoperative pacemaker complications. Anesthesiology 1985;63:319-22.
73. Levine PA, Balady GJ, Lazar HL, Belott PH, Roberts AJ. Electrocautery and pacemakers: management of the paced patient subject to electrocautery. Ann Thorac Surg 1986;41:313-7.
74. Lamas GA, Antman EM, Gold JP, Braunald NS, Collins JJ. Pacemaker backup-mode reversion and injury during cardiac surgery. Ann Thorac Surg 1986;41:155-7.
75. Heller LI. Surgical electrocautery and the runaway pacemaker syndrome. PACE 1990;13:1084-5.
76. Lichter I, Borrie J, Miller WM. Radio-frequency hazards with cardiac pacemakers. Br Med J 1965;1:1513-8.
77. Gould L, Patel C, Betzu R, Judge D, Lee J. Pacemaker failure following electrocautery. Clin Prog Electophysiol Pacing 1986;4:53-5.
78. Aylward P, Blood R, Tonkin A. Complications of defibrillation with permanent pacemaker in situ. PACE 1979;2:462-4.
79. Sager DP. Current facts on pacemaker electromagnetic interference and their application to clinical care. Heart Lung 1987;16:211-21.
80. Ruggera PS. Electrosurgical device interference with implanted pacemakers. JAMA 1978;239:1910.
81. Palac RT, Hwang MH, Klodnycky ML, Loeb HS. Delayed pulse generator malfunction after DC countershock. PACE 1981;4:163-7.
82. Gould L, Patel S, Gomes GI, Chokshi AB. Pacemaker failure following external defibrillation. PACE 1981;4:575-7.
83. Astridge PS, Kaye GC, Whitworth S, et al. The response of implanted dual chamber pacemakers to 50 Hz extraneous electrical interference. PACE 1993;16:1966-74.
84. Kim SG, Furman S, Matos JA, et al. Automated cardioverter/defibrillator: inadvertent discharges during permanent pacemaker magnet tests. PACE 1987;10:579-82.
85. Karson TH, Grace K, Denes P. Stereo speaker silences automatic implantable cardioverter-defibrillator. N Engl J Med 1989;320:1628-9.
86. Ferrick KJ, Johnston D, Kim SG, et al. Inadvertent AICD inactivation while playing bingo. Am Heart J 1991;1:206-7.
87. Bonnet CA, Elson JJ, Fogoros RN. Accidental deactivation of the automatic implantable cardioverter defibrillator. PACE 1990;13-546.
88. O'Flaherty D, Wardill M, Adams AP. Inadvertent suppression of a fixed rate ventricular pacemaker using a peripheral nerve stimulator. Anaesthesia 1993;48:687-9.
89. Schmitt C, Brachmann J, Waldecker B, et al. Implantable cardioverter defibrillator: possible hazards of electromagnetic interference. PACE 1991;14:982-4.
90. Naegeli B, Osswald S, Deola M, Burkart F. Intermittent pacemaker dysfunction caused by digital mobile telephones. J Am Coll Cardiol 1996;27:1471-7.
91. Jones SL. Electromagnetic field interference and cardiac pacemakers. Phys Ther 1976;56:1013-8.
92. Council on Dental Materials and Devices Possible electromagnetic interference with cardiac pacemakers from dental induction casting machines and electrosurgical devices. J Am Dent Assoc 1973;86:426.
93. Lau CP, Linker NJ, Butrous GS, Ward DE, Camm AJ. Myopotential interference in unipolar rate responsive pacemakers. PACE 1989;12:1324-30.
94. Youmans CR Jr, Bourianoff G, Allensworth DC, Martin WL, Derrick JR. Electroshock therapy and cardiac pacemakers. Am J Surg 1969;118:931-7.
95. Van Gelder LM, El Gamal MIH. Externally induced irreversible runaway pacemaker. PACE 1981;4:578-81.
96. Goldschlager N, Lesh M. Pacemaker communications. PACE 1993;16:1637-8.
97. Fein RL. Transurethral electrocautery procedures in patients with cardiac pacemakers. JAMA 1967;202:101-3.
98. Erdman S, Levinsky L, Servadio C, Stoupel E, Levy MJ. Safety precautions and management of patients with pacemakers when electrocautery operations are performed. Surg Gynecol Obstet 1988;167:311-4.
99. Irnich W, de Bakker JMT, Bisping HJ. Electromagnetic interference in implantable pacemakers. PACE 1978;1:52-61.
100. Pinski SL. Emergencies related to implantable cardioverter- defibrillators. Crit Care Med 2000;28(Suppl):N174-80.
101. Leshin B, Whitaker DC, Swanson NA. An approach to patient assessment and preparation in cutaneous oncology. J Am Acad Dermatol 1988;19:1081-8.
102. Furman S. Electrosurgical device interference with implanted pacemakers. JAMA 1978;239:1910.
103. Vilos G, Latendresse K, Gan BS. Electrophysical properties of electrosurgery and capacitive induced current. Am J Surg 2001;182:222-5.